Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Graft vs host disease].

V Moalic1, C Ferec

  • 1Laboratoire de génétique moléculaire et d'histocompatibilité, centre hospitalier universitaire Augustin-Morvan, 2, avenue Foch, 29200 Brest, France. virginie.moalic@chu-brest.fr

Pathologie-Biologie
|March 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The multi-faceted nature of 15 CFTR exonic variations: Impact on their functional classification and perspectives for therapy.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2022
Same author

Penetrance is a critical parameter for assessing the disease liability of CFTR variants.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2020
Same author

Genetics of cystic fibrosis: Basics.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2020
Same author

Overexpression of certain transient receptor potential and Orai channels in prostate cancer is associated with decreased risk of systemic recurrence after radical prostatectomy.

The Prostate·2019
Same author

CFTR gene variants: a predisposition factor to aquagenic palmoplantar keratoderma.

The British journal of dermatology·2019
Same author

Functional characterization and phenotypic spectrum of three recurrent disease-causing deep intronic variants of the CFTR gene.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2018
Same journal

Pathologie-biologie·2020
Same journal

Antibacterial and antibiofilm activities of Laurus nobilis L. essential oil against Staphylococcus aureus strains associated with oral infections.

Pathologie-biologie·2015
Same journal

[Not Available].

Pathologie-biologie·2015
Same journal

Oxidative damage and histopathological changes in lung of rat chronically exposed to nicotine alone or associated to ethanol.

Pathologie-biologie·2015
Same journal

Biological diagnosis of diabetes mellitus.

Pathologie-biologie·2015
Same journal

Association of CagPAI integrity with severeness of Helicobacter pylori infection in patients with gastritis.

Pathologie-biologie·2015
See all related articles

Graft versus host disease (GvHD) is a major complication of allogeneic stem cell transplants. Understanding its complex causes and developing strategies to separate GvHD from the beneficial graft-versus-leukemia effect is crucial for improving patient outcomes.

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Oncology

Context:

  • Allogeneic haematopoietic cell transplantation (HCT) is a life-saving procedure.
  • Graft versus host disease (GvHD) is a significant immunological complication following HCT.
  • GvHD contributes to substantial morbidity and mortality in transplant recipients.

Purpose:

  • This review synthesizes the physiopathological basis of GvHD.
  • It examines risk factors, clinical manifestations, and current management strategies.
  • The aim is to provide a comprehensive overview of GvHD in the context of HCT.

Summary:

  • GvHD arises from donor T lymphocytes reacting against foreign host cells.
  • Its complex pathophysiology involves host tissue damage, cytokines, and immune effectors like T cells and antigen-presenting cells.

Related Experiment Videos

  • Mechanisms of apoptosis also play a role in GvHD pathogenesis.

    • Impact:

    • Advances in understanding GvHD have transformed HCT practices.
    • There is increasing recognition of the graft-versus-leukemia (GvL) effect.
    • Separating GvHD from GvL is a key challenge, driving research into novel immunotherapies.